Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
55.21
+3.25 (6.25%)
At close: May 12, 2025, 4:00 PM
55.35
+0.14 (0.25%)
After-hours: May 12, 2025, 7:52 PM EDT
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $586.01M in the quarter ending March 31, 2025, with 110.67% growth. This brings the company's revenue in the last twelve months to $1.78B, up 85.99% year-over-year. In the year 2024, Hims & Hers Health had annual revenue of $1.48B with 69.33% growth.
Revenue (ttm)
$1.78B
Revenue Growth
+85.99%
P/S Ratio
6.75
Revenue / Employee
$1,090,014
Employees
1,637
Market Cap
12.36B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 680.99B |
Costco Wholesale | 264.09B |
PepsiCo | 91.52B |
The Procter & Gamble Company | 83.93B |
Unilever | 62.91B |
Anheuser-Busch InBev | 58.85B |
The Coca-Cola Company | 46.89B |
Philip Morris International | 38.39B |
HIMS News
- 8 hours ago - Hims & Hers Health Stock: A Rare High-Growth Value Play In Plain Sight - Seeking Alpha
- 10 hours ago - Hims & Hers: Still Undervalued For These 2 Reasons - Seeking Alpha
- 11 hours ago - Hims & Hers: Short-Lived Turbulence To Be Followed By New Phase Of Profitable Growth - Seeking Alpha
- 17 hours ago - Hims & Hers: Wegovy Deal Opens New Growth Chapter - Missed The Rally? Selling Puts Could Yield 30% - Seeking Alpha
- 3 days ago - Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare - Business Wire
- 4 days ago - Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started - Benzinga
- 4 days ago - Hims & Hers: The Road To Blue Chip Status - Seeking Alpha
- 4 days ago - Top 3 Health Care Stocks That Could Sink Your Portfolio In Q2 - Benzinga